1. Home
  2. TURB vs GTBP Comparison

TURB vs GTBP Comparison

Compare TURB & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turbo Energy S.A.

TURB

Turbo Energy S.A.

HOLD

Current Price

$1.48

Market Cap

16.5M

Sector

N/A

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.32

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TURB
GTBP
Founded
2013
1965
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5M
17.7M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
TURB
GTBP
Price
$1.48
$0.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
144.9K
942.5K
Earning Date
04-17-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.75
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.26
52 Week High
$20.44
$2.21

Technical Indicators

Market Signals
Indicator
TURB
GTBP
Relative Strength Index (RSI) 48.90 37.09
Support Level $1.42 $0.26
Resistance Level $1.78 $0.44
Average True Range (ATR) 0.14 0.04
MACD -0.00 -0.01
Stochastic Oscillator 23.18 5.26

Price Performance

Historical Comparison
TURB
GTBP

About TURB Turbo Energy S.A.

Turbo Energy SA is an integrator of AI-driven energy storage and intelligent energy management solutions focused on transforming how energy is generated, stored, optimized, and consumed across residential, commercial, industrial, and utility-scale applications. It operates at the intersection of renewable energy infrastructure, energy storage, and software-driven optimization, combining battery systems, solar integration, and proprietary Artificial Intelligence (AI) technologies into unified intelligent energy platforms. Its solutions are designed to help customers reduce energy costs, improve operational resilience, increase energy independence, and optimize energy performance in increasingly decentralized and volatile energy markets. It generates the majority of its revenue from Spain.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: